abstract |
The present invention relates, in part, to agents that bind to PD-1 or PD-L1 and their use as therapeutic and diagnostic agents. The present invention further relates to pharmaceutical compositions comprising PD-1 and PD-L1 binding agents, and their use in the treatment of various diseases. |